Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404

Single-arm phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients over 70 with previously treated metastatic colorectal adenocarcinoma FFCD 1404 – REGOLD

Published:2020-11 Issue:8 Volume:11 Page:1255-1262
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Aparicio Thomas,Darut-Jouve Ariane,Khemissa Akouz Faiza,Montérymard Carole,Artru Pascal,Cany Laurent,Romano Olivier,Valenza Bruno,Le Foll Christine,Delbaldo Catherine,Falandry Claire,Norguet Monnereau Emmanuelle,Ben Abdelghani Meher,Smith Denis,Rinaldi Yves,Père Verge Denis,Baize Nathalie,Maillard Emmanuel,Dohan Anthony,Des Guetz Gaetan,Pamoukdjian Frédéric,Lepage Come

Funder

Bayer HealthCare SAS, France

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference29 articles.

1. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 – results from the EUROCARE-5 study;Holleczek;Eur J Cancer,2015

2. Colorectal cancer care in elderly patients: unsolved issues;Aparicio;Dig Liver Dis,2016

3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

4. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial;Bennouna;Lancet Oncol,2013

5. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen;Van Cutsem;J Clin Oncol,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis;Cancers;2023-07-06

2. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study;Biomolecules and Biomedicine;2023-06-08

3. Trifluridine/tipiracil (FTD/TPI) and regorafenib in older patients with metastatic colorectal cancer;Journal of Geriatric Oncology;2023-05

4. Oncological Treatment-Related Fatigue in Oncogeriatrics: A Scoping Review;Cancers;2022-05-17

5. Traitement oncologique médical du cancer colorectal chez la personne âgée;Soins Gérontologie;2022-03